Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20123
20141
20151
20161
20182
20202
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Orion Corporation, Orion Pharma2
Sanofi2
AstraZeneca1
Bracco Diagnostics, Inc1
Celcuity Inc1
CureVac1
Genentech, Inc.1
Incyte Corporation1
Institut Cancerologie de l'Ouest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms18
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms2
Head and Neck Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Endometrial Neoplasms1
Erectile Dysfunction1
Gallbladder Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.